Showing results (191-200 of 388) with videos related to
Sort By:
Pageof 39
European Journal of Cancer (Oxford, England : 1990)|August 10, 2015
Metastatic medulloblastoma in adults: outcome of patients treated according to the HIT2000 protocolAndré O von Bueren, Carsten Friedrich, Katja von Hoff, et al.Neuro-Oncology|September 4, 2012
Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and HematologyAstrid K Gnekow, Fabian Falkenstein, Stephan von Hornstein, et al.Klinische Padiatrie|May 10, 2021
Doubling Recruitment of Pediatric Low-grade Glioma within Two Decades does not change Outcome - Report from the German LGG StudiesAstrid Katharina Gnekow, Daniela Kandels, Torsten Pietsch, et al.Acta Neuropathologica|October 1, 2022
Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomasTobias Goschzik, Martin Mynarek, Evelyn Doerner, et al.The American Journal of Pathology|June 13, 2012
Nuclear exclusion of TET1 is associated with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomasTim Müller, Marco Gessi, Anke Waha, et al.Neuro-Oncology|December 29, 2021
Evaluation of dose, volume, and outcome in children with localized, intracranial ependymoma treated with proton therapy within the prospective KiProReg StudySarah Peters, Julien Merta, Laura Schmidt, et al.International Journal of Cancer|March 22, 2007
Mutations of the Wnt antagonist AXIN2 (Conductin) result in TCF-dependent transcription in medulloblastomasArend Koch, Aksana Hrychyk, Wolfgang Hartmann, et al.Journal of Neuro-Oncology|January 11, 2014
Adults with CNS primitive neuroectodermal tumors/pineoblastomas: results of multimodal treatment according to the pediatric HIT 2000 protocolCarsten Friedrich, Klaus Müller, Katja von Hoff, et al.International Journal of Cancer|June 1, 2023
Neurosurgical morbidity in pediatric supratentorial midline low-grade glioma: Results from the German LGG studiesSarah Weiß, Ulrich-Wilhelm Thomale, Matthias Schulz, et al.Journal of Cancer Research and Clinical Oncology|November 23, 2019
Bevacizumab versus alkylating chemotherapy in recurrent glioblastomaKatharina Seystahl, Bettina Hentschel, Sarah Loew, et al.Pageof 39